Leading experts predict 2027 will be defined by the rise of autonomous AI agents and heightened cyber risks. While AI accelerates software development and security operations, it also expands attack surfaces, requiring new governance models, on-premises infrastructure shifts, and robust data integrity frameworks to maintain control.
SpaceX completed the largest IPO in history in June 2026, reaching a market value peak of over $2 trillion. This valuation shift is expected to drive significant catalysts for the company's stock performance in 2027, establishing a new financial center of gravity for the space sector.
The Seattle Mariners announced that catcher Cal Raleigh and third baseman Josh Naylor underwent surgeries on October 3, 2026. Raleigh had left shoulder AC debridement, while Naylor received a right wrist TFCC repair. Both are expected to be ready for spring training. The procedures follow a disastrous 2026 season where both stars saw significant performance declines, contributing to the team's first losing record since 2019.
Mizuho recommends two specific stocks for 2027, citing solid setups and 4% dividend yields, as investors navigate a market where long-term bond yields have recently outpaced equity income.
Byron Buxton will undergo arthroscopic surgery on his right hip next Friday, ending his 2026 season. Manager Derek Shelton confirmed the procedure, noting Buxton may be ready for the 2027 opener. The Twins, currently 69-77 and 4.5 games back from the playoffs, are shifting focus to long-term health. Buxton, who hit 25 home runs in 93 games this year, has never played more than 140 games in a season due to chronic hip issues. The team recently acquired Jeff Hoffman, Dean Kremer, and A.J. Minter at the deadline, signaling a push for contention despite Buxton's absence. Trevor Larnach trade rumors are expected, as the Twins have outfield depth with Walker Jenkins and Luke Keaschall. Buxton’s contract runs through 2028, and his availability remains a key factor for Minnesota’s future plans.